Cognitive Behavioural Therapy for Postpartum Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether online group cognitive behavioral therapy (CBT) can improve how babies manage their emotions when their mothers have postpartum depression (PPD). The study compares mothers receiving CBT alongside their usual care to those continuing only with their usual postnatal care. It is open to women in Ontario with symptoms of postpartum depression and an infant aged 4-12 months. Participants will join a 9-week online CBT group while continuing any existing healthcare.
As an unphased trial, this study offers mothers a unique opportunity to access innovative support that could enhance emotional well-being for both themselves and their babies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems like you can continue your usual treatment while participating in the study.
What prior data suggests that group cognitive behavioral therapy (CBT) is safe for postpartum depression?
Research has shown that group cognitive behavioral therapy (CBT) is generally safe for treating postpartum depression (PPD). Participants usually handle CBT well, according to studies. One study noted that even online CBT effectively helps mothers with PPD without causing major side effects. Another study recommended CBT as a first choice for many women with PPD, highlighting its safety and effectiveness. Most participants reported positive experiences and improvements in their mental health, with very few negative effects.12345
Why are researchers excited about this trial?
Researchers are excited about using group Cognitive Behavioural Therapy (CBT) for postpartum depression because it offers a unique approach compared to typical treatments like medication or individual therapy. This treatment is delivered online over nine weeks, making it more accessible to new mothers who might find it difficult to attend in-person sessions. Additionally, the group setting provides peer support, which can enhance the therapeutic experience by allowing participants to share experiences and strategies in a collaborative environment. This method aims to provide effective relief for postpartum depression while being convenient and supportive.
What evidence suggests that group CBT is effective for postpartum depression?
Research has shown that Cognitive Behavioral Therapy (CBT) effectively treats postpartum depression (PPD). Studies have found that CBT reduces depression in new mothers. In this trial, participants in the treatment arm will undergo a 9-week online group CBT intervention, which is convenient and fits into busy schedules. One study found that group CBT for PPD improves mood and overall well-being. This therapy works by changing negative thoughts and behaviors, leading to better mental health. Overall, evidence supports CBT as a powerful tool for managing PPD.12467
Who Is on the Research Team?
Ryan Van Lieshout, MD, PhD
Principal Investigator
Mcmaster
Are You a Good Fit for This Trial?
This trial is for English-speaking women over 18 living in Ontario with postpartum depression, as indicated by an EPDS score of at least 10. Their infants should be aged between 4-8 months. Women with bipolar disorder, current psychotic disorders, substance abuse issues, or certain personality disorders cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 9-week online group Cognitive Behavioral Therapy (CBT) intervention for Postpartum Depression (PPD) delivered via Zoom
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of maternal anxiety, infant temperament, and emotion regulation
What Are the Treatments Tested in This Trial?
Interventions
- Group Cognitive Behavioural Therapy (CBT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor